Show simple item record

dc.contributor.authorAsamblea Mundial de la Salud, 55
dc.coverage.spatialGinebraen
dc.date.accessioned2013-05-12T16:22:25Z
dc.date.available2013-05-12T16:22:25Z
dc.date.issued2002
dc.identifier.govdocA55/12
dc.identifier.urihttp://www.who.int/iris/handle/10665/81904
dc.description7 p.en
dc.description55ª Asamblea Mundial de la Salud, punto 13.8 del orden del día provisionalen
dc.language.isoesen
dc.publisherOrganización Mundial de la Saluden
dc.subjectPharmaceutical productsen
dc.subjectEssential medicinesen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshDrugs, Essentialen
dc.subject.meshDrug Costsen
dc.subject.meshDrug Industryen
dc.subject.meshDrug Delivery Systemsen
dc.subject.meshHealth Systems Plansen
dc.subject.meshDeveloping Countriesen
dc.titleEstrategia farmacéutica de la OMS: ampliación del acceso a los medicamentos esenciales: informe de la Secretaríaen
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen
dc.subject.meshqualifiereconomicsen
dc.subject.meshqualifiersupply and distributionen
who.relation.languageVersion10665/81442en
who.relation.languageVersion10665/78466en
who.relation.languageVersion10665/82317en
who.relation.languageVersion10665/80929en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record